Overview A Study of the Effect of Estrogen on Estrogen Receptor Biomarkers in Healthy Postmenopausal Women (0000-094)(COMPLETED) Status: Completed Trial end date: 2008-10-01 Target enrollment: Participant gender: Summary This study will develop a model for the assessment of successful activation/engagement of estrogen receptor beta using salivary biomarkers. Phase: Phase 1 Details Lead Sponsor: Merck Sharp & Dohme Corp.Treatments: EstradiolEstradiol 17 beta-cypionateEstradiol 3-benzoateEstradiol valerateEstrogensPolyestradiol phosphate